Filing Details

Accession Number:
0001179110-13-006446
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-03 20:21:04
Reporting Period:
2013-04-01
Filing Date:
2013-04-03
Accepted Time:
2013-04-03 20:21:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1012140 Onyx Pharmaceuticals Inc ONXX Biological Products, (No Disgnostic Substances) (2836) 943154463
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1225509 M Suzanne Shema C/O Onyx Pharmaceuticals, Inc.
249 E. Grand Ave.
South San Francisco CA 94080
Evp, Gc And Corp. Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-04-01 572 $89.60 39,261 No 4 S Direct
Common Stock Disposition 2013-04-01 1,500 $91.78 37,761 No 4 S Direct
Common Stock Disposition 2013-04-01 808 $86.14 36,953 No 4 S Direct
Common Stock Disposition 2013-04-01 2,335 $86.14 34,618 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. The shares were sold at prices ranging from $91.50 to $91.93. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Shares sold pursuant to a 10b5-1 arrangement.